Syneos Health, Inc.

About Syneos Health, Inc.

Syneos Health is a leading fully integrated biopharmaceutical solutions organization focused on accelerating customer success. They translate unique clinical, medical affairs, and commercial insights into outcomes to address modern market realities, aiming to speed the delivery of important therapies to patients worldwide.

Products & Services

Clinical Development:Services covering early phase to Phase II-IV trials, including real-world evidence, regulatory affairs, drug safety, pharmacovigilance, bioanalytical services, and decentralized clinical trials.

Commercial Delivery:Full-service commercialization solutions including deployment solutions, field sales teams, medical science liaisons, patient support services, market access, and healthcare advertising.

Medical Affairs:Support for medical communications and strategies to enhance therapy delivery.

Consulting:Strategic consulting services for biopharmaceutical companies.

Therapeutic Depth:Expertise in specific therapeutic areas like oncology, cardiovascular, neuroscience, and rare diseases.

Technology & Data:AI and tech-enabled insights through platforms like Kinetic™ and Synopsis for healthcare business intelligence and clinical study oversight.

FSP 360:Customized functional service provider solutions for clinical development.

Specialties

Oncology and Hematology Cardiovascular Neuroscience Rare Diseases Clinical Development Commercialization Regulatory Affairs Pharmacovigilance Real-World Evidence AI and Tech-Enabled Insights

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Acquisition T: - FT: Acquisition	A: 43 MR: - FA: $43.00 per share FAN: 43	D: 2023-09-28 FD: 2023-09-28	3 investors
2	RT: Debt T: - FT: Debt	A: 1700000000 MR: - FA: $1,700,000,000 FAN: 1700000000	D: 2023-09-06 FD: 2023-09-06	3 investors
3	RT: Acquisition T: - FT: Acquisition	A: 43 MR: - FA: $43.00 per share FAN: 43	D: 2023-08-02 FD: 2023-08-02	3 investors

Acquisition Latest

2023-09-28

$43

3 investors (Pro only)

Debt 2023-09-06

$1.7B

Acquisition 2023-08-02

$43

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Mike Montello

Chief Digital and Information Officer

J

Jon Olefson

General Counsel and Corporate Secretary

M

Martin Luther King Jr.

C

Costa Panagos

Chief Executive Officer

M

Michael Brooks

Chief Operating Officer

M

Michael Bonello

Chief Financial Officer

View 6 more team members with Pro

Unlock Full Team Directory

Recent News